Senegal raised 101 billion CFA francs ($179 million) in a government securities auction on Friday, its first sale since announcing plans to seek a reworking of its external debt. The result suggests ...

As the cost of test rises with complexity of AI and other advanced devices, system-level test with integrated test cells is becoming a foundational approach. Traditional test insertions such as wafer ...

Standard memory tests such as word-pair or list-learning tests used in clinics may fail to detect the real-life memory problems reported by many female breast cancer survivors after chemotherapy. A ...

COLORADO SPRINGS, Colo. (KRDO) -- Two Colorado Springs emergency departments are the first in the state to use a new blood test that can assess whether a patient may have a mild brain injury and avoid ...

The case of 2-year-old Annelise Camp, who was found unconscious in May, drew the backing of anti-abortion activists. On Monday, the family decided to remove life support. By Pooja Salhotra Annelise ...

LONDON — A protein marker of Alzheimer’s disease in the brain may also help diagnose cases of the brain condition chronic traumatic encephalopathy, or CTE, early data suggest. The condition, which is ...

Challenge yourself with a clever riddle and see if you can solve what most people miss. #Riddle #BrainTeaser #Fun Air Force lieutenant colonel, wife barely fed 9-year-old living in closet, nicknamed ...

Airmen at Moody Air Force Base, Georgia, take an Automated Neuropsychological Assessment Metrics, or ANAM, test. (Joshua Green/U.S. Air Force) The Defense Department is updating its Cognitive ...

Pete Hegseth, as defense secretary, has sought to cultivate an image as a manosphere-friendly leader. By Greg Jaffe and Azeen Ghorayshi Greg Jaffe covers the U.S. military, and Azeen Ghorayshi reports ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers ...